✦ LIBER ✦

Comparison of [177Lu-DOTA0,Tyr3]octreotate and [177Lu-DOTA0,Tyr3]octreotide: which peptide is preferable for PRRT?

✍ Scribed by J. P. Esser; E. P. Krenning; J. J. M. Teunissen; P. P. M. Kooij; A. L. H. van Gameren; W. H. Bakker; D. J. Kwekkeboom

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[177Lu-DOTA0,Tyr3]octreotate: comparison

✍ Dik J. Kwekkeboom; Willem H. Bakker; Peter P. Kooij; Mark W. Konijnenberg; Anant 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 96 KB

[177Lu-DOTA0,Tyr3]octreotate for somatos

✍ Marion de Jong; Wout A.P. Breeman; Bert F. Bernard; Willem H. Bakker; Michael Sc 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 243 KB

Long-term toxicity of [177Lu-DOTA0,Tyr3]

✍ Edgar J. Rolleman; Eric P. Krenning; Bert F. Bernard; Monique de Visser; Magda B 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 344 KB

Effects of therapy with [177Lu-DOTA0,Tyr

✍ Jaap J. M. Teunissen; Eric P. Krenning; Frank H. de Jong; Yolanda B. de Rijke; R 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 242 KB

Bone marrow dosimetry in peptide recepto

✍ Flavio Forrer; Eric P. Krenning; Peter P. Kooij; Bert F. Bernard; Mark Konijnenb 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 219 KB

Amifostine protects rat kidneys during p

✍ Edgar J. Rolleman; Flavio Forrer; Bert Bernard; Magda Bijster; Marcel Vermeij; R 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 218 KB